|
Composition
|
Name
|
Position
|
Institution
|
|
|
Jefe de Servicio de Alergología
|
Hospital Universitario La Paz
|
|
María Pilar Encarnación Barranco Sanz
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
María Teresa Caballero Molina
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
María Luisa Caballero Soto
|
Facultativo Especialista de Área en Inmunología
|
Hospital Universitario La Paz
|
|
Francisco Javier Contreras Porta
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
Leticia de las Vecillas Sánchez
|
Facultativo Especialista en Alergología
|
Hospital Universitario La Paz
|
|
Francisco Javier Domínguez Ortega
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
Ana María del Carmen Fiandor Román
|
Jefe de Sección de Alergologia
|
Hospital Universitario La Paz
|
|
Carmen Gómez Traseira
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
Juan Alberto Luna Porta
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
María Magdalena Lluch Bernal
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
María Pedrosa Delgado
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
Elsa Phillips Angles
|
Facultativo Especialista de Área en Alergología Pediátrica
|
Hospital Universitario La Paz
|
|
Mónica Rodríguez Álvarez
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
María Rosa Rodríguez Pérez
|
Investigadora Senior (Contrato Miguel Servet- Tipo 2)
|
Hospital Universitario La Paz
|
|
Margarita Tomás Pérez
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
|
Ana María Umpiérrez Rodríguez
|
Facultativo Especialista de Área en Alergología
|
Hospital Universitario La Paz
|
Strategic Objective
These group members are specialists in various areas of allergic diseases, which enable them to perform clinical studies and basic research on the main allergic diseases (food allergies, asthma and rhinitis, urticaria/ angiooedema and drug allergies). The group’s strategic research objectives include:
• The development of new techniques to improve the diagnosis of food allergies by determining the molecular sensitisation profile
• The treatment of food allergies with oral desensitisation protocols
• The study of hyperresponsiveness and airway inflammation in asthma, as well as the role of allergen exposure and comorbidities in this disease
• The study of the pathogenesis and treatment of eosinophilic diseases of the airways (eosinophilic bronchitis) and the gastrointestinal tract (eosinophilic oesophagitis)
• The characterisation of various types of angiooedema caused by Bradykinin (hereditary and acquired) and improvements in their diagnosis and treatment
• Research on the epidemiology and pathomechanisms of severe adverse reactions caused by immune hypersensitivity reactions to drugs
Research Lines
• Food allergy (milk, egg, fruit, cereals): molecular diagnosis (by allergenic components) and treatment with oral desensitisation
• Epidemiology, physiopathology, diagnosis and treatment of angioedema and urticaria
• Studies on bronchial hyperresponsiveness to direct and indirect agents and airway inflammation
• Eosinophilic diseases of the respiratory tract (eosinophilic bronchitis) and digestive system (eosinophilic esophagitis)
• Persistent and difficult to control asthma: study on the influence of common and occupational allergens, comorbidities and new therapies
• Aspirin-exacerbated respiratory disease (AERD): inflammatory markers and desensitisation protocol
• Adverse immunologic reactions to drugs: study on the cellular and molecular mechanisms involved.
• Molecular basis of allergy: characterization of allergens and modulating factors of allergenicity. Novel allergy biomarkers: microRNAs and mRNAs. Seeking the differences of specific IgE between allergic patients and asymptomatic individuals.
Portfolio of services
Questionnaire Hereditary Angioedema-Quality of Life (HAE-QoL)
Questionnaire to assess the health related quality of life in adult patients with Hereditary Angioedema due to C1 Esterase Inhibitor Deficiency.
Procedure to get access to HAE-QoL:
1. Download both versions -English and Spanish- of the non-disclosure agreement (NDA), fill in all the information related with you, the organization for which you work and its legal representative; sign and send to the mailing address:
Foundation for Biomedical Research of La Paz University Hospital-IdiPAZ [“Fundación para la Investigación Biomédica del Hospital Universitario La Paz-IdiPAZ”]
Paseo de la Castellana, 261
Edificio Norte. Planta 4ª
Madrid 28046
Spain
Non-disclosure agreement English version
2. Once both versions of the NDA have been signed you should send to the same email address ( maria.dolores.perez@idipaz.es) a brief summary of the project in which you wish to apply the questionnaire, specifying whether it is an individual/non- collaborative project or, on the contrary, is a project in collaboration with an institution / organization and, if so, we would need to know the name of that institution / organization (pharmaceutical company, etc.).
3. Then we will send you a contract for licensing the use of the questionnaire, which will be free of charge or on a fee-paying basis according to the characteristics of your project, and once signed, you will receive the HAE-QoL questionnaire, the dossier and the scoring instructions.
|